A Closer Look at Sinoveda's Technology for Developing Combination Drugs
/PRNewswire/ -- The health world is often divided between powerfully precise synthetic Western drugs and ancient, often-inconsistent natural Eastern medicinal...
Stay updated with breaking news from Platform Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The health world is often divided between powerfully precise synthetic Western drugs and ancient, often-inconsistent natural Eastern medicinal...
Results Indicative that CTx-1301 Provides Entire Active-Day Efficacy with Optimal Onset and DurationKANSAS CITY, Kan., July 11, 2023 -- Cingulate Inc. , a biopharmaceutical company utilizing its...
The Gibraltar Betting and Gaming Association (GBGA) has announced that Paul Foster has resigned as its chief executive.
Lonza Group AG / Key word(s): Acquisition/Mergers & Acquisitions Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering 01.06.2023 / 07:00 CET/CEST Lonza to acquire
Significant YTD Progress in Neurology and Oncology Programs New financing of $5MM closed without warrants, derivatives or other financial considerations ROCHESTER, N.Y., May 15, 2023 -- Vaccinex,... | May 15, 2023